1. Factors Related to Placebo Response in Randomized, Double-Blind Clinical Trials of Antidepressants in Children and Adolescents: A Meta-regression Analysis

   • Risa Okubo
   • Kazuhiro Matsui
   • Mamoru Narukawa

   Systematic Review 24 May 2023 Pages: 383 - 391

   

2. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

   • Emily E. Leppien
   • Bennett J. Doughty
   • Kenneth L. McCall

   Original Research Article 15 May 2023 Pages: 393 - 399

   

3. A Phase I Study to Evaluate the Pharmacokinetic Drug‒Drug Interaction of HP501, Febuxostat, and Colchicine in Male Chinese Patients with Hyperuricemia

   • Ruilin Ding
   • Longxia Chen
   • Qing Peng

   Original Research Article 30 May 2023 Pages: 401 - 411

   

4. Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers

   • Yingxin Li
   • Yang Li
   • Aixin Shi

   Original Research Article Open access 03 June 2023 Pages: 413 - 420

   

5. Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects

   • Sufeng Zhou
   • Jinying Zhu
   • Feng Shao

   Original Research Article 04 June 2023 Pages: 421 - 433

   

6. The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese Volunteers

   • Junyu Xu
   • Nan Zhao
   • Yimin Cui

   Original Research Article 16 June 2023 Pages: 435 - 445

   

7. Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN²COVID Phase I Randomized Trial

   • Diego Garcia-Huidobro
   • Carolina Iturriaga
   • the IN²COVID Research Team

   Original Research Article 22 June 2023 Pages: 447 - 461